FDA Inspection
Webrx dba RxPalace.comWebrx dba RxPalace.com – FDA Inspection, Dec 28, 2017
Record Details
This FDA Inspection record concerns Webrx dba RxPalace.com, with an inspection on December 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Christie A. Garcia (Issuing Officer)
View Company Profile
ID · 2736fee6-105c-4605-9ab1-62ccd87b5abc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1036614
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.84(d)(2)Component identification test
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.